As a result of research and innovation in multiple sclerosis (MS), over the past 20 years the MS community has seen patient pathways transformed.

Although we still have a lot to learn, research into the underlying biology, advanced monitoring methods, and new therapeutic options have shortened the journey to both diagnosis and treatment, reducing disease progression for people with relapsing MS (RMS).

  • Blue: Diagnosed ~20 years ago

  • Green: Diagnosed more recently

Explore the hypothetical pathway of a person with relapsing MS diagnosed ~20 years ago and hear about real experiences from people with MS and physicians.